Pharmacy and Therapeutics Committee (P&T)


By statute (NRS 422.402-422.405), the State of Nevada requires the DHCFP to establish and maintain a Preferred Drug List (PDL). The Pharmacy and Therapeutics Committee (P&T) was established to identify prescription drugs to be included on the PDL. The PDL is not restricted formulary. Drugs not on the PDL are still available to recipients if they meet the Standard Preferred Drug List Exception criteria.

The P&T committee consists of at least 9 but not more than 11 members who are Governor-appointed physicians and pharmacists. Members must be licensed to practice in the State of Nevada and either an actively practicing physician or an actively practicing pharmacist. The DHCFP Chief of Pharmacy Services serves as Coordinator to the P&T Committee. Meetings are held quarterly and are open to the public. Anyone wishing to address the P&T Committee may do so. Public comment is limited to 5 minutes per speaker/organization (due to time constraints). Anyone presenting documents for consideration must provide sufficient copies for each committee member and a copy (electronic preferred) for the official record.

For pharmacists and physicians wishing to serve on the Pharmacy & Therapeutics Committee, please visit the Governor's Boards and Commissions webpage using the link provided on the right.